by Truveta staff | Jul 1, 2024 | News
In this post, I would like to discuss the way we addressed the following challenge: How to ensure that the AI technologies used in our platform have requisite accuracy and explainability while assuring fairness and avoidance of bias Healthcare and life science...
by Truveta staff | Jun 17, 2024 | News
Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
by Truveta staff | May 30, 2024 | News
This post is the first of six deep dives I plan to do into the significant technology challenges we have solved at Truveta using the power of AI to enable healthcare research using real-world data. Today I would like to talk about our approach to answering: How to...
by Truveta staff | May 14, 2024 | News
Truveta Research and collaborators Anupam B. Jena, MD, PhD and Christopher Worsham, MD, MPH received the ISPOR 2024 Best General Poster Research Presentation Award for their poster presentation, HSD72: Baseline A1C and BMI Trends for People with Type 2 Diabetes...
by Truveta staff | May 13, 2024 | News
Today Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors ensures Truveta is operating in pursuit of its mission, providing strategic, scientific, and operational direction. With...
by Truveta staff | May 1, 2024 | News
Today we are excited to announce the availability of expanded concepts from clinical notes — including family history, medication details reported to providers, and complex concepts for a wide range of therapeutic areas from cardiology to rare disease and more –...
